Azoospermia, Nonobstructive clinical trials
The registry lists 23 studies for Azoospermia, Nonobstructive across more than 10 countries. 7 are recruiting or about to start. 17 of them are mainly about Azoospermia, Nonobstructive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the Azoospermia, Nonobstructive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Assiut University (2) · Acibadem University (1) · Clinique Ovo (1) · IRCCS San Raffaele (1) · A.O.U. Città della Salute e della Scienza (1) · Duzce University (1) · Herlev and Gentofte Hospital (1) · Hospices Civils de Lyon (1)
What is being tested here
Drugs under test in Azoospermia, Nonobstructive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Isotretinoin | 1 | 0 | 1 |
| Platelet rich plasma | 1 | 0 | 1 |
| Letrozole | 0 | 1 | 1 |
| Clomiphene | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Dec 2026Platelet Rich Plasma Testis Treatment for Infertile Men · Stanford University
- Apr 2027Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in Men · The Third Affiliated Hospital of Guangzhou Medical University
- Jun 2027Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm · University of Nebraska
Who these studies take
Of the 6 Azoospermia, Nonobstructive studies recruiting now, 2 (33%) set no upper age limit and 2 (33%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 4 (67%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (17%) | 1 (17%) |
| 18 | 2 (33%) | 5 (83%) |
| 30 | 2 (33%) | 6 (100%) |
| 40 | 2 (33%) | 6 (100%) |
| 50 | 2 (33%) | 6 (100%) |
| 65 | 2 (33%) | 5 (83%) |
| 75 | 2 (33%) | 5 (83%) |
| 85 | 2 (33%) | 4 (67%) |
Across all 23 studies, recruiting or not: 57% stop at 75 or younger and 48% at 65; 9% take children; 0% are for women only and 87% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in MenRecruitingNCT076918271 country
- Isotretinoin vs hCG for Male Infertility Due to Low or Absent SpermEnrolling by invitationNCT07481370Phase 21 country
- Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)RecruitingNCT073577011 country
- Platelet Rich Plasma Testis Treatment for Infertile MenRecruitingNCT05479474Not applicable1 country
- Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®RecruitingNCT06869863Phase 1/21 country
- 2015-Metabolomics&Microbiome-infertilityRecruitingNCT061818511 country
- The Potential of Sperm Retrieved by Micro-TESE to Fertilize Vitrified/Warmed OocytesRecruitingNCT038090261 country
- Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis AspirationActive, not recruitingNCT032915221 country
- Evaluation of Assisted Reproductive Technology (ART) Outcomes in Couples With Nonobstructive Azoospermia, Cryptozoospermia, and Severe OligozoospermiaCompletedNCT078972791 country
- Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm CellsWithdrawnNCT03615547Phase 31 country
- Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOACompletedNCT074159281 country
- Autologous Transplantation of Human Cryopreserved Testis TissueActive, not recruitingNCT07364409Not applicable1 country
- Timing of Oocyte Retrieval and Micro Testicular Sperm ExtractionCompletedNCT072682351 country
- Management of Non Obstructive Azoospermia in MenCompletedNCT06983626Not applicable1 country
- TeSE (Testicular Sperm Extraction) in Azoospermic Patients: m-TeSE vs. l-TeSECompletedNCT06702397Not applicable1 country
- Machine Learning Based-Personalized Prediction of Sperm Retrieval Success RateCompletedNCT063587941 country
- Hormonal Stimulation of SpermatogenesisCompletedNCT05483621Phase 11 country
- Seminal Level of Clusterin Before Testicular Sperm ExtractionStatus unknownNCT03857828
- The Effects of Intratesticular PRP Injection in Men With Azoospermia or CryptozoospermiaCompletedNCT04237779Not applicable1 country
- Seminal TEX101 as a Predictor of Recovery of Spermatogenesis in Azoospermic Men With Palpable VaricoceleCompletedNCT04397887Not applicable1 country
- TESE and Non Obstructive AzoospermiaStatus unknownNCT03146260Not applicable
- Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.CompletedNCT02900105Phase 31 country
- GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive AzoospermiaStatus unknownNCT02544191Phase 21 country